Research News and Research

RSS

Joslin.org and dLife.com announce new online partnership

Joslin.org, the Internet site for Harvard-affiliated Joslin Diabetes Center, the world's preeminent diabetes research and clinical care organization, and dLife.com, the leading online community for people living with diabetes, today announced a new online partnership.

29 Jan 2010

Diffusion Pharmaceuticals closes on $5.9M in additional private financing

Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat serious or life-threatening unmet medical conditions, today announced that it closed on $5.9 million in additional private financing during the second half of 2009, bringing the total the company raised in 2009 to $7.1 million.

29 Jan 2010

Positive Phase 2 trial results of Keryx Biopharmaceuticals' KRX-0401 announced

Keryx Biopharmaceuticals, Inc. (the "Company") today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of KRX-0401 (Perifosine) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of Clinical Cancer Research.

29 Jan 2010

Recent releases in Global Health

Rajiv Shah's appointment as USAID administrator "comes at a crucial time of challenge and opportunity for the Agency to improve the nutritional well-being of impoverished societies," write the authors of a Lancet Comment that examines the U.S. Global Hunger and Food Security Initiative. Though the initiative "sends a clear message to the world about U.S. intent to partner with poor nations to achieve their national food and nutrition goals … the Initiative's nutrition plan, unlike its detailed agricultural blueprint, currently lacks a comprehensive set of aims, activities, research needs, and programme benchmarks," the authors write.

29 Jan 2010

New mathematical model helps in predicting treatment outcomes for cervical cancer patients

Cervical cancer is highly curable when caught early. But in a third of cases, the tumor responds poorly to therapy or recurs later, when cure is much less likely.

29 Jan 2010

Health bill - 'on life support' - continues to highlight political divides

President Obama's State of the Union speech has so far failed to unite Democrats on a health reform strategy as they "stared down a political nightmare," The Associated Press reports.

29 Jan 2010

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

The Company's net loss for the quarter ended October 31, 2009 amounted to $2.5 million or ($0.01) per share, compared to $10.9 million or ($0.04) per share, for the quarter ended October 31, 2008.

29 Jan 2010

Democrats offer varying views on health overhaul's fate

NPR interviewed House Energy and Commerce Committee Chairman Henry Waxman, D-Calif., to get his reactions to the President's Wednesday night speech.

29 Jan 2010

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Published reports on the usefulness of CT scans for complicated H1N1 cases have spurred use of these procedures in U.S. hospitals. According to healthcare market research publisher Kalorama Information, this opens up a pathway of diagnostics for physicians and overall is a positive sign not only for the technology but also for companies making chemical agents for procedures.

29 Jan 2010

Claims by Obama, leading Republican gain fact-checker attention

"Proponents of reform have lost control over the message because people think it's too complicated to understand. Confused about important details of the proposals, the public is susceptible to misrepresentations by opponents," CBS News reports.

29 Jan 2010

IDEXX Laboratories reports revenues for fourth-quarter of 2009

IDEXX Laboratories, Inc., today reported that revenues for the fourth quarter of 2009 increased 11% to $270.3 million, from $243.3 million for the fourth quarter of 2008.

29 Jan 2010

Quantrx Biomedical signs agreement to acquire NuRx Pharmaceuticals

QuantRx Biomedical Corporation today announced that it has entered into an agreement to acquire NuRx Pharmaceuticals, Inc. (OTCBB: NUXP). The transaction is structured as a tax-free, all stock acquisition resulting in a combined company with no debt and a simplified ownership and capital structure.

29 Jan 2010

First Edition: January 29, 2010

Today's news highlights the Democrats' continuing struggle to find a way forward on health reform.

29 Jan 2010

New guidance may help minimize risks to patient privacy in clinical trials

New guidance published in the open access journal Trials and bmj.com this week sets out how personal information from clinical trials should be shared to help minimize risks to patient privacy.

29 Jan 2010

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

Bill and Melinda Gates announced today that their foundation will commit $10 billion over the next 10 years to help research, develop and deliver vaccines for the world's poorest countries.

29 Jan 2010

BioCentric Energy to grow algae strain with high EPA/DHA oil content in V3 Algae-Pro systems

BioCentric Energy is pleased to announce that the final engineering on the V3 Algae-Pro Photobioreactor system is now complete. We have received via shipment from China the 32 Corners for the V3 Alga-Pro system. Also received at the Santa Ana headquarters are the 8,000 lineal feet of proprietary, seven layer tubing. Installation of the V3 Algae-Pro system will commence over the next two weeks.

29 Jan 2010

ECCO supports its member organisations' proposals for adapting the EU Clinical Trials Directive

In response to a European Commission consultation on the EU Clinical Trials Directive, ECCO - the European CanCer Organisation - has supported proposals by its member organisations for adapting the Directive's requirements to reflect practical necessities in cancer research and treatment.

29 Jan 2010

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

ChromoCure, Inc. -- The Company announced today, based on the recent validation of its cancer detection approach and efficacy of its proprietary Chromosomal Scanning Technology, that it has retained Patent & Intellectual Property Attorneys to assess its growing Intellectual Property portfolio and secure necessary filings and Patent protections.

29 Jan 2010

Sexual infidelity or emotional infidelity - which is more distressing?

When South Carolina Governor Mark Sanford was caught red-handed returning from a tryst with his Argentine mistress last June, he told the Associated Press that he had met his "soul mate." His choice of words seemed to suggest that having a deep emotional and spiritual connection with Maria Belen Chapur somehow made his sexual infidelity to his wife Jenny Sanford less tawdry.

29 Jan 2010

BBVA Foundation Frontiers of Knowledge Award granted to Robert J. Lefkowitz

The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category goes in this second edition to Prof. Robert J. Lefkowitz (1943, New York, United States), investigator in the Department of Medicine at Duke University (United States).

29 Jan 2010

Research News and Research

Joslin.org and dLife.com announce new online partnership

Diffusion Pharmaceuticals closes on $5.9M in additional private financing

Positive Phase 2 trial results of Keryx Biopharmaceuticals' KRX-0401 announced

Recent releases in Global Health

New mathematical model helps in predicting treatment outcomes for cervical cancer patients

Health bill - 'on life support' - continues to highlight political divides

ConjuChem Biotechnologies reports financial results for fiscal year ended October 31, 2009

Democrats offer varying views on health overhaul's fate

Agent-enhanced CT scan plays a supporting role in diagnosing severe cases of H1N1 flu virus

Claims by Obama, leading Republican gain fact-checker attention

IDEXX Laboratories reports revenues for fourth-quarter of 2009

Quantrx Biomedical signs agreement to acquire NuRx Pharmaceuticals

First Edition: January 29, 2010

New guidance may help minimize risks to patient privacy in clinical trials

Bill & Melinda Gates Foundation commits $10 billion for vaccine research and development

BioCentric Energy to grow algae strain with high EPA/DHA oil content in V3 Algae-Pro systems

ECCO supports its member organisations' proposals for adapting the EU Clinical Trials Directive

ChromoCure retains Patent & Intellectual Property Attorneys to assess its Intellectual Property portfolio

Sexual infidelity or emotional infidelity - which is more distressing?

BBVA Foundation Frontiers of Knowledge Award granted to Robert J. Lefkowitz

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring